Dr Evangelos Russo was appointed as a consultant gastroenterologist at Imperial College Healthcare NHS Trust in 2017. He previously completed his specialist training in north west Thames, and a PhD degree at Imperial College London focused on inflammatory bowel disease. He has a strong interest in colonoscopy and polypectomy and is a core member of the lower GI cancer multi-disciplinary team. He has a wide portfolio of endoscopic procedures including diagnostic and therapeutic gastroscopy, BRAVO pH monitoring, diagnostic and therapeutic colonoscopy and polypectomy as well as endoscopic full-thickness resection.
His other clinical interest and focus of clinical research is inflammatory bowel disease as well as microscopic colitis, a common but often underdiagnosed cause of chronic diarrhoea. He also has wide experience in the investigation and management of a wide range of GI conditions including abdominal pain, dyspepsia and reflux, change in bowel habit, GI bleeding and irritable bowel syndrome.
Additional languages spoken: French, Greek
HIs publications include:
EA Russo, SA Khan, R Janisch, RN Gunn, EA Rabiner, SA Taylor, PM Matthews, TR Orchard. The role of 18F-fluorodeoxyglucose positron emission tomography in the monitoring of inflammatory activity in Crohn’s disease. Inflamm Bowel Dis 2016 – In press
A Plumb, A Menys, EA Russo, D Prezzi, G Bhatnagar, R Vega, S Halligan, TR Orchard, SA Taylor. Magnetic resonance imaging-quantified small bowel motility is a sensitive marker of response to medical therapy in Crohn’s disease. Aliment Pharmacol Ther. 2015 Aug;42(3):343-55
P Kennedy, EA Russo, N Kumar, N Powell, P Vlavianos, A Thillainayagam, D Bansi, D Westaby. Effectiveness of prophylactic pancreatic stents in preventing post-ERCP pancreatitis: A two-year retrospective controlled study in a tertiary centre in London.
Surg Endosc. 2010 Aug;24(8):1923-8
EA Russo, M Iacucci, JO Lindsay, S Campbell, JP Hamlin, TR Orchard, N Arebi, AL Hart, SM Gabe, MR Jacyna, J Nightingale, M O’Connor, AW Harris, C O’Morain, S Ghosh.
Survey regarding the use of adalimumab as maintenance therapy in Crohn’s disease in England and Ireland.
Eur J Gastroenterol Hepatol. 2010 Mar;22(3):334-9.
EA Russo, AW Harris, S Campbell, J Lindsay, A Hart, N Arebi, A Milestone, HH Tsai, J Walters, M Carpani, D Westaby, A Thillainayagam, D Bansi, S Ghosh.
Experience of maintenance infliximab therapy for refractory ulcerative colitis in England.
Aliment Pharmacol Ther. 2009 Feb 1;29(3):308-14.